Loading...
ROCO
1788
Market cap179mUSD
Jul 09, Last price  
129.50TWD
1D
0.00%
1Q
-5.13%
Jan 2017
42.83%
IPO
192.59%
Name

Hi-Clearance Inc

Chart & Performance

D1W1MN
ROCO:1788 chart
P/E
15.65
P/S
1.35
EPS
8.28
Div Yield, %
5.41%
Shrs. gr., 5y
1.70%
Rev. gr., 5y
4.51%
Revenues
4.28b
+5.04%
1,582,951,0001,741,924,0001,764,417,0001,850,030,0002,023,232,0002,129,177,0002,381,451,0002,649,891,0002,691,841,0002,739,916,0002,832,628,0002,958,880,0003,095,154,0003,240,723,0003,431,968,0003,684,006,0004,689,687,0003,895,778,0004,072,811,0004,278,234,000
Net income
369m
+2.45%
108,040,000114,344,000104,783,000113,927,000139,561,000141,776,000186,673,000219,111,000219,654,000216,886,000207,557,000251,077,000243,449,000245,737,000317,294,000348,594,000366,428,000347,984,000359,688,000368,510,000
CFO
401m
-21.45%
130,553,000-16,689,000188,142,000148,365,000137,993,000-249,396,000378,027,00032,236,00049,447,000328,021,000242,698,000314,225,000256,667,000413,162,000287,794,000403,164,000433,488,000510,119,000400,698,000
Dividend
Jun 23, 20257 TWD/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Established in 1989 and headquartered in New Taipei City, Taiwan, Hi-Clearance Inc. is a prominent supplier of medical devices and associated services throughout Taiwan. The company's comprehensive product range addresses various healthcare sectors, including renal care, cardiac health, radiation therapy, dentistry, oral surgery, and metabolic conditions. Its medical offerings encompass vital equipment such as dialyzers, dialysis machines, and reverse osmosis (RO) systems, complemented by essential consumables and pharmaceutical products. Hi-Clearance also provides specialized devices for interventional cardiology, radiology, and vascular surgery. For the dental field, it supplies consumables, implant materials, and equipment. Furthermore, the company offers blood glucose monitors, along with their related consumables and nutritional products. Beyond product provision, Hi-Clearance Inc. delivers extensive hemodialysis management services and specializes in the development and operation of dialysis centers. Diversifying its business, the company also engages in the distribution and servicing of healthy and natural beverages, and acts as an OEM provider for beverage raw materials and concentrates.
IPO date
Sep 10, 2004
Employees
Domiciled in
TW
Incorporated in
TW

Valuation

Title
TWD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT